GLP-1s can save health system money if priced below $350 a month: analysis

详细摘要

CVS Health's Aetna claims analysis finds GLP-1s priced below $350 a month could yield net savings for payors through reduced health care use. Read more here.

An analysis of insurance claims data found that if GLP-1 medications for weight loss and diabetes are priced below $350, it results in net savings for payors, such as employers and plan sponsors, through reduced use of health care services that result.

文章开头，摘自Seeking Alpha。如需阅读全文，请前往媒体网站。